These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness. Høgh AL Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205 [TBL] [Abstract][Full Text] [Related]
9. Secondary prevention of coronary artery disease. Hall SL; Lorenc T Am Fam Physician; 2010 Feb; 81(3):289-96. PubMed ID: 20112887 [TBL] [Abstract][Full Text] [Related]
10. Management of acute coronary syndromes. Schulman SP; Fessler HE Am J Respir Crit Care Med; 2001 Sep; 164(6):917-22. PubMed ID: 11587971 [No Abstract] [Full Text] [Related]
11. [Treatment of coronary insufficiency in diabetics: Part 2: acute coronary insufficiency]. Grand A Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):119-27. PubMed ID: 12555336 [TBL] [Abstract][Full Text] [Related]
12. Use of secondary preventive medications after the first attack of acute coronary syndrome. Salomaa V; Pääkkönen R; Hämäläinen H; Niemi M; Klaukka T Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):386-91. PubMed ID: 17568237 [TBL] [Abstract][Full Text] [Related]
13. [Secondary prevention of coronary heart disease]. von Schacky C MMW Fortschr Med; 2003 Mar; 145(13):28, 30, 32-3. PubMed ID: 15101529 [TBL] [Abstract][Full Text] [Related]
14. [Therapeutic strategies to improve the outcome of patients with diabetes mellitus and acute coronary syndrome]. Cavallini C G Ital Cardiol (Rome); 2006 Apr; 7(4 Suppl 1):13S-20S. PubMed ID: 16749287 [TBL] [Abstract][Full Text] [Related]
15. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study). Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D; Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158 [TBL] [Abstract][Full Text] [Related]
16. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Anselmino M; Malmberg K; Ohrvik J; Rydén L; Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651 [TBL] [Abstract][Full Text] [Related]
17. Improving the adverse cardiovascular prognosis of type 2 diabetes. O'Keefe JH; Miles JM; Harris WH; Moe RM; McCallister BD Mayo Clin Proc; 1999 Feb; 74(2):171-80. PubMed ID: 10069357 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials. Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817 [TBL] [Abstract][Full Text] [Related]
19. Follow-up of hemorheological parameters and platelet aggregation in patients with acute coronary syndromes. Marton Z; Horvath B; Alexy T; Kesmarky G; Gyevnar Z; Czopf L; Habon T; Kovacs L; Papp E; Mezey B; Roth E; Juricskay I; Toth K Clin Hemorheol Microcirc; 2003; 29(2):81-94. PubMed ID: 14610303 [TBL] [Abstract][Full Text] [Related]
20. Effect of insulin-glucose infusion on mortality following acute myocardial infarction in patients with diabetes: the diabetes and insulin-glucose infusion in acute myocardial infarction studies. Malmberg K; Rydén L Semin Thorac Cardiovasc Surg; 2006; 18(4):326-9. PubMed ID: 17395029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]